Increased plasma complement factor H is associated with geriatric depression.


Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 26 5 2018
medline: 19 12 2019
entrez: 26 5 2018
Statut: ppublish

Résumé

ABSTRACTBackground:Complement factor H (CFH) plays a key role in regulating the cascade of the alternative pathway of the complement system. Dysregulation of CFH may be involved in the pathophysiology of various inflammation-mediated diseases including neuropsychiatric illnesses. This study aimed to investigate this relationship by examining determining CFH levels in elderly individuals with and without depression. A total of 152 elderly individuals (major depressive disorder (MDD) group, n = 76; comparison sample, n = 76) were selected from the Ansan Geriatric study. The plasma level of CFH was measured. MDD was diagnosed with the Mini-International Neuropsychiatric Interview as per DSM-IV criteria. The severity of depression was evaluated with the geriatric depression scale (GDS). Mean CFH levels were compared using the Mann-Whitney U test. After adjusting for possible confounding factors including age, sex, marital status, education, alcohol use, hemoglobin levels, and the Korean version of the Mini-Mental State Examination (MMSE-KC), a multiple regression analysis was conducted. The GDS score and plasma level of CFH were analyzed using Spearman's correlation. Plasma CFH level was significantly higher in individuals with MDD than in the comparison sample (289.51 ± 21.16 vs. 339.67 ± 66.23, p < 0.001). In a regression model adjusted for possible confounders, CFH was significantly associated with geriatric depression (p < 0.001). CFH levels were not significantly related to GDS scores in the depressed group. This study revealed an association between high plasma levels of CFH and geriatric depression, thereby suggesting the alternative pathway of the complement system contributing to the development of geriatric depression.

Identifiants

pubmed: 29798743
pii: S1041610218000558
doi: 10.1017/S1041610218000558
doi:

Substances chimiques

Biomarkers 0
Complement Factor H 80295-65-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-108

Auteurs

Cheolmin Shin (C)

Department of Psychiatry,College of Medicine,Korea University,Seoul,Republic of Korea.

Byung-Joo Ham (BJ)

Department of Psychiatry,College of Medicine,Korea University,Seoul,Republic of Korea.

Young-Hoon Ko (YH)

Department of Psychiatry,College of Medicine,Korea University,Seoul,Republic of Korea.

Chi-Un Pae (CU)

Department of Psychiatry,College of Medicine,The Catholic University of Korea,Seoul,Republic of Korea.

Moon Ho Park (MH)

Department of Neurology,College of Medicine,Korea University,Seoul,Republic of Korea.

David C Steffens (DC)

Department of Psychiatry,University of Connecticut Health Center,Farmington,Connecticut,USA.

Ashwin A Patkar (AA)

Department of Psychiatry and Behavioural Sciences,Duke University Medical Center,Durham,North Carolina,USA.

Changsu Han (C)

Department of Psychiatry,College of Medicine,Korea University,Seoul,Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH